Our Southeast Asia team have advised Singapore medtech company eko.ai on its US$4million series A financing. The deal was led by Sequoia with SGInnovate, Partech Ventures and Startup Health participating in the funding round.eko.ai’s tools improve cardiovascular research and the performance of echocardiography clinical trials. Its machine learning platform automates the process of measuring and interpreting echocardiograms (ultrasound images of the heart).With the funding, eko.ai intends to grow its teamand push operations in the US and Europe with the ultimate goal of democratisingechocardiography globally.Co -founder James Harecommented. “There’s always challengeswhen closing a funding round with several investors, particularly in themedical space. The Kindrik Partners team have great venture capital experienceand helped us understand what VC terms were market standard for the region”.Healthtech businesses in Southeast Asia continue to attract investors. Last year Kindrik Partners advised Indonesian healthcare Alodokter on its US$33million series C financing and Lifetrack Medical Systems on its series A led by UOB Ventures Management and Phillips.
